9th Annual Biomarkers Congress
Co-Development of Drugs and Diagnostics


NW Washington, DC
http://www.nextgenerationdx.com/cdd
Co-Development of Drugs and Diagnostics

Schedule of Presentations:

Wednesday, August 25, 2010
11:00:00 Registration
12:05:00 PLENARY KEYNOTE SESSION
12:10:00 SHAPING THE FUTURE OF CANCER PATHWAY-BASED MEDICINE
12:15:00 Chairperson’s Remarks Harry Glorikian
12:20:00 Comprehensive Cancer Genome Diagnostics in the Era of Targeted Therapy Jeffrey S. Ross
12:50:00 Emerging Stakeholders in Personalized Medicine Harry Glorikian
13:20:00 Luncheon Presentation (Sponsorship Available) or Lunch on Your Own
14:05:00 UNDERSTANDING THE PROCESS
14:10:00 Chairperson’s Remarks Robert E. Yocher
14:15:00 Immunohistochemistry and Companion Diagnostics--Know Your Target, Start Early, Fail Often Robert Dunstan
14:45:00 The PMC Public Policy Efforts on Companion Diagnostics Robert E. Yocher
15:15:00 Evidence Based Evaluation of New Molecular Diagnostic Tests – Going for the Gold Steven Gutman
15:45:00 Networking Refreshment Break, Exhibit & Poster Viewing
16:30:00 New Challenges in Health Economics and Reimbursement Anita J. Chawla
17:00:00 Adoption of Companion Diagnostics by Industry and Academia Peter Tolias
17:30:00 Break-Out Sessions
17:35:00 Evaluating Commercial Need for a Companion Diagnostic - How Do You Decide? Charlie Raffin
18:30:00 End of Day
18:35:00 Dinner Short Course* | (SC3) FUTURE OF POINT-OF-CARE PLATFORMS Peter Miller, Keith F. Batchelder
Thursday, August 26, 2010
07:00:00 Registration
07:30:00 Breakfast Presentation (Sponsorship Available)
08:20:00 SUCCESSFUL PARTNERSHIPS IN PERSONALIZED MEDICINE
08:25:00 Chairperson’s Remarks Brian T. Edmonds
08:30:00 Tailored Therapeutics at Eli Lilly: Our Strategy for the Co-Development of Diagnostics with Therapeutics Brian T. Edmonds
09:00:00 Choosing a Biomarker Partner Cynthia Gawron-Burke
09:30:00 Diagnostic Test to Screen Non-Small Cell Lung Cancer Tumors for the Presence of Gene Rearrangements Hakan Sakul
10:00:00 Networking Coffee Break, Exhibit & Poster Viewing
10:45:00 The Drivers and Financial Benchmarks of Personalized Medicine Mollie Roth, Peter Keeling
11:15:00 Sponsored Presentations (Opportunities Available)
12:30:00 Luncheon Presentations (Sponsorship Available) or Lunch on Your Own
14:10:00 MODELS FOR COMPANION DIAGNOSTICS
14:15:00 Chairperson’s Remarks Charlie Raffin
14:20:00 Keynote Presentation | HLA Markers Predict Adverse Reactions from Drugs? Munir Pirmohamed
14:50:00 Lumiracoxib - Seeking a New Path Forward Through Use of a Companion Diagnostic Kevin Carl
15:20:00 How to Optimize Drug-Companion Diagnostics Co-Development between the Pharma- and Diagnostic Industries? Henrik Winther
16:00:00 Refreshment Break
16:30:00 Challenges of Co-Development of Therapeutics and Companion Diagnostics Andrea H. Lauber
17:00:00 The Joy of CDx: A Guide to K-RAS Pharma Partnering Stephen Little
17:30:00 Companion Diagnostics for EP4 Agonist IBD Therapy Christoph Borchers
18:00:00 Close of Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.